1. Introduction {#sec1-ijms-20-05028}
===============

The immune system is a defense system that protects organisms from invading pathogens, such as viruses or bacteria. It comprises a heterogeneous group of cells, i.e., immune cells, as well as cell-independent mechanisms. Immune cells can be broadly divided into two main categories according to their properties and defense mechanisms: cells of the innate and cells of the adaptive immune system. Cells from the innate immune system, namely macrophages, neutrophils, eosinophils, basophils, mast cells, natural killer cells, and dendritic cells, are the first cellular line of defense. Their mode of action is generally fast but with limited specificity. Cells from the adaptive immune system, namely B cells and T cells, have a higher level of specificity, but their activation is delayed. However, cells from the adaptive immune system develop memory against pathogens after a first confrontation, and their speed and efficiency against a previously faced pathogen is greatly enhanced during a second encounter.

Coordination of the different immune cells and regulation of their activity is of crucial importance for mounting an effective immune defense. This task is often accomplished by the secretion of cytokines and chemokines, i.e., molecules secreted by cells, including but not restricted to immune cells, that attract immune cells into the site of infection and regulate their activation or their suppression \[[@B1-ijms-20-05028],[@B2-ijms-20-05028]\].

A healthy and balanced diet is essential for the correct function of every part of our organism, including the immune system. Additionally, some dietary factors have been found to have immune-regulatory properties, including micronutrients such as Vitamin D or macronutrients such as fatty acids \[[@B3-ijms-20-05028]\]. The impact of dietary polyunsaturated fatty acids (PUFAs) on the immune system has been investigated for decades, with special focus on the omega-3 PUFAs α-linolenic acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA). ALA is found in nuts and seeds whereas EPA and DHA are the main components of fish oil \[[@B4-ijms-20-05028],[@B5-ijms-20-05028]\]. For a comprehensive review of the sources of omega-3 fatty acids, we recommend Cholewski et al. \[[@B6-ijms-20-05028]\].

EPA and DHA can also be synthesized from ALA \[[@B7-ijms-20-05028]\], a process that involves several steps orchestrated by multiple elongases, desaturases, and β-oxidases \[[@B8-ijms-20-05028]\]. However, the synthesis of EPA from ALA occurs at a low rate in mammals \[[@B9-ijms-20-05028]\]. Of note, the same enzymes are employed by omega-6 fatty acids for their metabolic pathways.

Both omega-3 and omega-6-derived metabolites have important immune-regulatory functions. These metabolites are generally known as pro-resolving mediators (SPMs) and can be classified in different families---prostaglandins, leukotrienes, thromboxanes, maresins, protectins, and resolvins. Their synthesis is orchestrated by cyclooxygenase, lipoxygenase, or cytochrome P450 enzymes \[[@B10-ijms-20-05028]\]. A summary of the metabolites produced from omega-3 fatty acids and the enzymes regulating their synthesis is found in [Figure 1](#ijms-20-05028-f001){ref-type="fig"}. Omega-3 and omega-6 substrates compete for these enzymes \[[@B11-ijms-20-05028]\], as well as for the above mentioned elongases and elastases. Therefore, in the presence of omega-3 fatty acids, the competition for the enzymes reduces the synthesis of omega-6-derived metabolites, which also have effects on immune cells. This competition constitutes an additional level of immune-regulation by omega-3 fatty acids.

Although the specific mechanisms of action of omega-3 fatty acid regulation of immune cells function present several cell type-specific features, it is worth mentioning that omega-3 fatty acids, via in vitro stimulation or via dietary supplementation, effectively incorporate into the cellular membrane of all the immune cells investigated to date \[[@B12-ijms-20-05028],[@B13-ijms-20-05028],[@B14-ijms-20-05028]\]. Polyunsaturated fatty acids possess multiple double bonds in their carbon chain. Since each double bond causes a bend in the carbon chain, polyunsaturated fatty acids cannot stack as tightly within cellular membranes as saturated fatty acids do. Therefore, the incorporation of polyunsaturated fatty acids increases the fluidity of cellular membranes \[[@B15-ijms-20-05028]\].

Several outstanding reviews describing the effects of omega-3 fatty acids on the immune system and their clinical effect on immune-related diseases are already available for the reader \[[@B16-ijms-20-05028],[@B17-ijms-20-05028],[@B18-ijms-20-05028],[@B19-ijms-20-05028]\]. The main aim of our review is to describe the specific effects of omega-3 fatty acids on the different types of immune cells focusing on the recent findings on the field (summarized in Table 1).

2. Effects of Omega-3 Fatty Acids on Macrophage Function {#sec2-ijms-20-05028}
========================================================

Macrophages have a fundamental role as part of the innate immune system. They patrol multiple organs in a constant search for invading pathogens. They are able to recognize specific pathogen-associated molecular patterns (PAMPs) thanks to the toll-like receptors (TLRs) present on their surface. After pathogen recognition, they initiate the elimination process of the pathogen by engulfing it (phagocytosis) and secreting anti-microbial molecules such as reactive oxygen species (ROS). Simultaneously, they produce and secrete a large variety of cytokines and chemokines in order to recruit and activate other immune cells from both the innate and the adaptive immune system to mount an efficient immune response to completely eliminate the threat. Macrophages activated by PAMPs and IFN-γ, known as classically activated or M1 macrophages, secrete TNF-α and IL-1β and direct their actions toward pathogen elimination. They produce antigenic peptides from the destroyed pathogen to present them to adaptive immune cells, which subsequently initiate a more specific immune response \[[@B20-ijms-20-05028]\]. In contrast, macrophages can also be activated by IL-4 into alternatively activated, or M2, macrophages, which secrete IL-10 and promote tissue repair \[[@B21-ijms-20-05028]\].

The impact of omega-3 fatty acids on macrophage function has extensively been investigated since the 1980s \[[@B22-ijms-20-05028],[@B23-ijms-20-05028]\]. Since then, there are three main properties of macrophage biology that have been identified to be altered by omega-3 fatty acids: the production and secretion of cytokines and chemokines, the capacity of phagocytosis, and the polarization into classically activated or alternatively activated macrophages. These investigations have been carried out both using in vitro and in vivo experimental approaches. Since the literature on the topic is extremely extensive, we focus in this review on the direct effects of fatty acids on macrophages found in vitro. In such experiments, the alterations observed in macrophage biology are more directly related to the treatment with omega-3 fatty acids and not by the communication with other cell types that could also be affected by the omega-3 fatty acids as it happens in the in vivo investigations.

Omega-3 fatty acids provoke major alterations on gene regulation on macrophages. Treatment of macrophages with DHA or EPA induces major changes in gene expression in THP-1-derived, LPS-activated macrophages \[[@B24-ijms-20-05028]\], although the effects of DHA and EPA are not identical. Whereas most of EPA-regulated genes belong to the cell cycle regulation family, most of DHA-regulated genes belong to immune response pathways. Similarly, the addition of the omega-3 fatty acids DHA and EPA into the growth cell culture medium for macrophages induces significant global changes in miRNA expression profile. Roessler et al. found that the incubation of Raw macrophage cell line with DHA, in combination with or without LPS, results in alterations in the expression of miRNAs regulating pathways related to gene expression, signal transduction, immune defense, growth/differentiation, and transport-associated genes \[[@B25-ijms-20-05028]\].

2.1. Regulation of the Production and Secretion of Cytokines in Macrophages by Omega-3 Fatty Acids {#sec2dot1-ijms-20-05028}
--------------------------------------------------------------------------------------------------

Probably the most renowned property of omega-3 fatty acids is their ability to reduce inflammation and their beneficial effect on inflammation-related disorders (we suggest the review on the topic by Calder, 2011, \[[@B26-ijms-20-05028]\]). For some of these diseases, it has been suggested that the cell type responsible for the inflammatory modulation by omega-3 fatty acids is macrophages \[[@B27-ijms-20-05028]\]. To date, the effects of omega-3 fatty acids on the production and secretion of cytokines and chemokines by macrophages have extensively been investigated, as well as the regulatory mechanisms behind them. Mildenberger et al. \[[@B28-ijms-20-05028]\] quantified the levels of 579 inflammation-related mRNA transcripts in LPS-stimulated human primary monocyte-derived macrophages (MDMs) pre-treated with DHA. Twenty-five percent of the quantified transcripts upregulated by LPS were attenuated by DHA pre-treatment. Downregulation of LPS-induced increase in cytokine gene expression by DHA or EPA has also been demonstrated in macrophage cell lines, such as Raw macrophages or THP-1-derived macrophages, as well as in primary mouse macrophages (bone marrow--derived macrophages and primary peritoneal macrophages) \[[@B24-ijms-20-05028],[@B29-ijms-20-05028],[@B30-ijms-20-05028],[@B31-ijms-20-05028],[@B32-ijms-20-05028],[@B33-ijms-20-05028],[@B34-ijms-20-05028]\]. Interestingly, the timing for the addition of the omega-3 fatty acids seems to play an important role. For example, addition of DHA to BMDMs after LPS stimulation does not alter mRNA levels of *TNFα* but it does reduce mRNA levels of *pro-IL1-β* \[[@B31-ijms-20-05028]\]. Allam-Ndoul et al. demonstrated that the most effective downregulation of LPS-induced mRNA expression of *il6*, *tnfα*, *il1β*, and *mcp1* genes in THP-1-derived macrophages was achieved after LPS stimulation for EPA but during LPS stimulation for DHA \[[@B35-ijms-20-05028]\]. Most studies currently employ pre-incubation with omega-3 fatty acids, however, additive effects of co-incubating macrophages with EPA and DHA has been demonstrated in Raw macrophages \[[@B36-ijms-20-05028]\] and in THP-1-derived macrophages \[[@B24-ijms-20-05028]\]. Of interest, pre-incubation of Raw macrophages with DHA also prevents the increase in the mRNA expression of *mcp1*, *il1a*, *il1b*, and *il6* when the inflammation is caused by a combination of LPS and the saturated fatty acid palmitic acid, suggesting that omega-3 fatty acids can effectively counteract the pro-inflammatory effects caused by saturated fatty acids \[[@B32-ijms-20-05028]\]. Last, not only DHA and EPA have been found to decrease gene expression of cytokines in macrophages in vitro, but also other derivatives from linolenic acid \[[@B33-ijms-20-05028]\]. Most of the above-mentioned studies found no changes induced by the incubation with omega-3 fatty acids in macrophages unless stimulated with LPS.

Investigations of the secreted levels of cytokines and chemokines confirmed the above described effects of omega-3 fatty acids on cytokine/chemokine gene expression in macrophages \[[@B24-ijms-20-05028],[@B37-ijms-20-05028],[@B38-ijms-20-05028]\]. Importantly, the anti-inflammatory properties of EPA and DHA on macrophages are not exclusive to LPS-induced inflammation. THP-1-derived macrophages incubated with ox-LDL (to mimic the formation of foam cells seen in diseases such as atherosclerosis) secreted higher levels of IL-6 and TNF-α than control macrophages, an increase that was successfully rescued by the incubation with omega-3 fatty acids \[[@B39-ijms-20-05028]\]. DHA and EPA also decrease cytokine secretion in Raw macrophages that were infected with *R. equi* or *P.aeruginosa* \[[@B40-ijms-20-05028]\] or stimulated with palmitic acid in combination with LPS \[[@B32-ijms-20-05028]\]. Two interesting facts can be drawn as well from these last two studies. First, the anti-inflammatory effect of DHA was more potent than the effect of EPA. Second, the only cytokine whose secretion was increased by the treatment with omega-3 fatty acids was the anti-inflammatory cytokine IL-10.

The omega-3 fatty acids EPA and DHA are able to suppress inflammasome-mediated inflammation with potency similar of that of the classical caspase-1 inhibitor YVAD \[[@B41-ijms-20-05028]\]. The inhibition of the NLRP3 inflammasome by EPA and DHA has been demonstrated in macrophage cell lines as well as in primary human and mouse macrophages \[[@B33-ijms-20-05028],[@B41-ijms-20-05028],[@B42-ijms-20-05028]\] and for wide range of inflammasome-activating stimuli \[[@B31-ijms-20-05028],[@B41-ijms-20-05028]\]. However, the pre-treatment of macrophages with EPA or DHA does not inhibit all kinds of inflammasome. As demonstrated by Yan et al. \[[@B31-ijms-20-05028]\], DHA, EPA, and ALA decrease IL-1β secretion in BMDMs stimulated with LPS and anthrax lethal toxin (activator of the NLRP1 inflammasome) but not in BMDMs stimulated with LPS and infected with *S. Typhimurium* or in BMDMs treated with LPS and poly (dA:dT) to activate the NLRC4 or the AIM2 inflammasomes respectively. A plausible mechanism behind omega-3 fatty acids-mediated inhibition of the NLRP3 inflammasome can be the decrease in the expression of the *nlrp3* gene \[[@B33-ijms-20-05028],[@B42-ijms-20-05028]\]. Interestingly, omega-3 fatty acid inhibition of the NLPR3 inflammasome requires PPARγ and GPR120/GRP40 signaling \[[@B31-ijms-20-05028],[@B33-ijms-20-05028]\].

Inflammation is a tightly regulated process in which many different receptors, signaling pathways, and transcription factors are involved. LPS-induced inflammation is triggered by the direct contact between LPS and its receptor TLR4. The signaling cascade downstream of TLR4 leads to the phosphorylation and nuclear translocation of transcription factors regulating the expression of cytokines, such as NFkB, MAPK, or ERK \[[@B43-ijms-20-05028]\]. Pre-treatment of LPS-stimulated Raw macrophages with DHA, not EPA or ALA, decrease *tlr4* mRNA \[[@B44-ijms-20-05028]\] however, no changes have been found in the gene expression for other factors involved in the TLR4 downstream signaling \[[@B44-ijms-20-05028]\]. Pre-treatment of Raw macrophages with EPA or DHA does not alter the global surface expression of TLR1, TLR2, TLR4, TLR6, or CD14 \[[@B38-ijms-20-05028],[@B45-ijms-20-05028]\], although an increased localization of TLR4 and CD14 upon EPA or DHA treatment has been found specifically in the macrophage membrane lipid rafts \[[@B44-ijms-20-05028]\].

Decreased LPS-induced phosphorylation, nuclear translocation, and transcriptional activity of NFkB by pre-treatment with omega-3 fatty acids have been demonstrated in primary macrophages and macrophage cell lines with EPA, DHA, or the plant-derived omega-3 fatty acid steridonic acid \[[@B32-ijms-20-05028],[@B33-ijms-20-05028],[@B46-ijms-20-05028],[@B47-ijms-20-05028]\]. EPA and DHA are also able to decrease NFkB activation induced by the TLR2 ligand PamCAG \[[@B46-ijms-20-05028]\]. Decreased activation by EPA or DHA treatment has also been described for other transcription factors such as IRF3, STAT-1, STAT-3, IRF1, ERK1/2, JNK, and MAPK \[[@B28-ijms-20-05028],[@B47-ijms-20-05028]\] but not for others such as CREB \[[@B34-ijms-20-05028]\]. However, how omega-3 fatty acids exert this modulation on inflammatory transcription factors activation remains largely unknown. It has been shown that DHA and other ALA derivatives decrease ROS and NO production \[[@B33-ijms-20-05028],[@B47-ijms-20-05028]\] in LPS-stimulated macrophages, which could be associated with decreased transcription factor activation. Also, DHA and EPA have been found to regulate miRNA expression in Raw and THP-1-derived macrophages that could add an additional regulatory level of the inflammatory transcription factors \[[@B25-ijms-20-05028],[@B48-ijms-20-05028]\].

2.2. Effects on Macrophage Polarization by Omega-3 Fatty Acids {#sec2dot2-ijms-20-05028}
--------------------------------------------------------------

The evidence supporting the anti-inflammatory properties of omega-3 fatty acids on macrophages, mainly decreasing the secretion of IL-1β, TNF-α, and IL-6, already backs the notion that omega-3 fatty acids blunt M1 macrophage polarization upon LPS stimulation. Additionally, omega-3 fatty acids have been found to promote M2 polarization in macrophage cell lines and primary mouse macrophages \[[@B29-ijms-20-05028],[@B30-ijms-20-05028],[@B49-ijms-20-05028]\]. Treatment of macrophages with ALA, DHA, or other ALA-omega-3 derivatives increases mRNA expression of *Arg1* \[[@B49-ijms-20-05028]\], *cd36*, *il10*, and *tgfβ* \[[@B29-ijms-20-05028]\] and the surface expression of CD206 \[[@B49-ijms-20-05028]\]. These effects were abolished when GPR40 was blocked \[[@B49-ijms-20-05028]\] or PPARγ was silenced \[[@B29-ijms-20-05028]\]. Omega-3-induced polarization of macrophages towards an M2 phenotype has been successfully employed to reduce brain injury upon stroke \[[@B50-ijms-20-05028]\] and alleviate atopic dermatitis \[[@B51-ijms-20-05028]\].

2.3. Effects of Omega-3 Fatty Acids on the Phagocytic Capacity of Macrophages {#sec2dot3-ijms-20-05028}
-----------------------------------------------------------------------------

Although the treatment with omega-3 fatty acids decreases M1 polarization of macrophages, ALA, DHA and EPA can increase the phagocytic capacity of macrophages. This omega-3 fatty acid-mediated increase in the phagocytic capacity has been demonstrated for the engulfment of zymosan particles \[[@B29-ijms-20-05028]\], *R.Equi*, *P.aeruginosa* \[[@B52-ijms-20-05028]\], *E.coli* \[[@B53-ijms-20-05028]\], as well as phagocytosis of apoptotic cells \[[@B29-ijms-20-05028]\]. Some investigators have suggested that this increase in the phagocytic capacity of macrophages upon omega-3 treatment could be related to changes in the cellular membrane composition and structure caused by the incorporation of the omega-3 fatty acids \[[@B44-ijms-20-05028],[@B54-ijms-20-05028]\], although causation still remains to be confirmed.

3. Effects of Omega-3 Fatty Acids on Neutrophil Function {#sec3-ijms-20-05028}
========================================================

The most abundant leukocyte in humans is the neutrophil. The vast majority of mature neutrophils are found in the circulation, blood, and the marginal pools (bone marrow, spleen, and liver), whereas a small portion is found in tissues \[[@B55-ijms-20-05028],[@B56-ijms-20-05028],[@B57-ijms-20-05028]\]. Neutrophils are the first cells to be recruited to the site of inflammation \[[@B58-ijms-20-05028]\] and have an important role in the clearance of pathogens. However, neutrophils can also interact with the adaptive immune system by promoting naïve T cells to transition into T helper 1 cells and can present antigens to B-cells in the spleen \[[@B59-ijms-20-05028]\].

Omega-3 fatty acids have been shown to be incorporated into phospholipids in the cell membrane of neutrophils at the expense of the omega-6 fatty acids linoleic and arachidonic acid \[[@B13-ijms-20-05028],[@B60-ijms-20-05028]\]. Once the omega-3 fatty acids have been incorporated into the phospholipids, they can be metabolized by neutrophils into prostaglandins, leukotrienes, thromboxanes, maresins, protectins, and resolvins \[[@B10-ijms-20-05028],[@B61-ijms-20-05028],[@B62-ijms-20-05028]\]. Omega-3 fatty acids, and their metabolites, modulate neutrophil function in several ways, including neutrophil migration, phagocytic capacity, as well as the production of reactive oxygen species and cytokines.

3.1. Effects on Neutrophil Migration and Transmigration by Omega-3 Fatty Acids {#sec3dot1-ijms-20-05028}
------------------------------------------------------------------------------

Several omega-3-derived metabolites have been found to inhibit migration of neutrophils both in vitro and in vivo. The omega-3 fatty acid metabolite resolving D1 reduces neutrophil migration in a microfluidic system \[[@B63-ijms-20-05028]\]. In line with these findings, Krishnamoorthy et al. showed that human polymorphonuclear leukocytes have, after incubation with resolvin D1, a decrease in actin polymerization, which subsequently leads to reduced neutrophil migration \[[@B64-ijms-20-05028]\].

Endothelial cells are involved in the migration of neutrophils by producing prostaglandin D2 (a metabolite derived from the omega-6 fatty acid arachidonic acid). When prostaglandin D2 binds to its receptor, DP-1 on neutrophils, it leads to neutrophil adhesion and transmigration. However, if endothelial cells are treated with EPA, the omega-3 fatty acid induces a switch in the endothelial cells toward the production of prostaglandin D3, with opposing effects compared with prostaglandin D2 \[[@B65-ijms-20-05028]\]. Further, one of the metabolites from DHA, resolvin D3, reduces the number of transmigrated neutrophils in a mice-peritonitis model \[[@B66-ijms-20-05028]\]. Another group of omega-3 fatty acid derived lipid mediators, the maresins, also inhibit neutrophil infiltration \[[@B67-ijms-20-05028],[@B68-ijms-20-05028]\]. Both protectin D1 and aspirin-triggered protectin D1 (AT-PD1) reduce neutrophil infiltration into the peritoneum of mice upon TNF-α-induced peritonitis \[[@B69-ijms-20-05028]\].

Surprisingly, when human volunteers were given fish oil supplementation and blood neutrophil migration capacity was investigated, fish oil supplementation led to increased migration capacity of neutrophils \[[@B70-ijms-20-05028]\]. However, it should be noted that the assay used by Gorjao et al. \[[@B70-ijms-20-05028]\] was ex vivo, whereas Dalli et al. \[[@B66-ijms-20-05028]\] made use of the in vivo mouse peritonitis model. Further, there is a time-dependent factor when investigating the omega-3 fatty acids effect on neutrophil migration Arnardottir et al. \[[@B71-ijms-20-05028]\] demonstrated in a peritonitis model that fewer neutrophils had migrated into the peritoneal cavity at 12 h, whereas at 48 h, more neutrophils had migrated into the peritoneal cavity compared with control mice.

3.2. Effects of Omega-3 Fatty Acids on the Phagocytic Capacity of Neutrophils {#sec3dot2-ijms-20-05028}
-----------------------------------------------------------------------------

Omega-3 fatty acids have been shown to improve the phagocytic capacity in neutrophils in mice \[[@B72-ijms-20-05028]\]. In vitro, adding DHA to extracted peritoneal neutrophils leads to a 35% increase in phagocytic capacity as well as a two-fold increase in fungicidal capacity \[[@B4-ijms-20-05028]\]. Interestingly, EPA did not affect the phagocytic capacity in the same experiment. Polymorphonuclear leukocytes from goats incubated with either EPA or DHA had increased capacity to phagocytose *E. coli* compared with control \[[@B73-ijms-20-05028]\]. This effect has partly been confirmed in humans too. Ten volunteers were given fish oil supplementation containing 26% EPA and 54% DHA daily for two months. Thereafter, the phagocytic capacity of the neutrophils in the blood was increased with 62% \[[@B70-ijms-20-05028]\]. In another study, healthy volunteers were either given supplementation with corn oil (mostly linoleic acid, omega-6 fatty acids) or EPA. Interestingly, this led to a no effect on phagocytic capacity tested with *E. coli* in vitro \[[@B74-ijms-20-05028]\]. This might indicate that the effect on phagocytic capacity is due to DHA.

3.3. Effects of Omega-3 Fatty Acids on the Production of Reactive Oxygen Species {#sec3dot3-ijms-20-05028}
--------------------------------------------------------------------------------

Omega-3 fatty acids can influence neutrophil ROS production; however, the effect varies depending on animal model used as well as age (in humans). Both EPA and DHA increase the production of ROS in a dose-dependent manner in rat neutrophils, with a greater increase by EPA \[[@B4-ijms-20-05028]\]. In goat polymorphonuclear leukocytes, the production of reactive oxygen species is decreased by DHA and not affected by EPA \[[@B73-ijms-20-05028]\]. In humans, supplementation with 54% DHA and 26% EPA for two months increased ROS production in phorbol-myristate-acetate stimulated neutrophils \[[@B70-ijms-20-05028]\]. However, since the supplementation contains both EPA and DHA, it is not obvious which fatty acid causes the effect on ROS production. Another experiment on humans was conducted by Rees et al. Healthy volunteers were either given supplementation with the linoleic-rich corn oil or EPA. Interestingly, EPA supplementation led to a decrease in ROS production in older men, but there was no change in younger men \[[@B74-ijms-20-05028]\].

3.4. Other Aspects {#sec3dot4-ijms-20-05028}
------------------

Not only the function but also the number of neutrophils seems to be affected by omega-3 fatty acids. A diet rich in omega-3 PUFAs increases the frequency of neutrophils, as well as the number of CD117+ precursor cells, in bone marrow \[[@B72-ijms-20-05028]\] and the frequency of neutrophils in the spleen and the liver in homeostatic conditions \[[@B75-ijms-20-05028]\]. Dietary supplementation with fish oil also increases the number of neutrophils in the bone marrow and in the spleen of SMAD3 KO mice, with a more pronounced effect in male mice \[[@B76-ijms-20-05028]\]. In humans, dietary supplementation of fish oil in healthy volunteers does not alter the number of circulating neutrophils \[[@B77-ijms-20-05028]\].

The functions of neutrophils are not limited to migration, phagocytosis of pathogens and ROS production. They also secrete cytokines to orchestrate the immune response as well as cytotoxic proteins upon degranulation and they produce neutrophil extracellular traps (NETs) to immobilize pathogens \[[@B78-ijms-20-05028]\]. To date, the reports investigating the effects of omega-3 fatty acids on these neutrophil functions are extremely scarce. Only two reports describe direct regulation of omega-3 fatty acids on neutrophil cytokine production. A report in 2013 demonstrated that EPA and DHA increase cytokine secretion (CXCL3, TNF-α and IL-1-β, respectively) in LPS-stimulated rat peritoneal neutrophils \[[@B4-ijms-20-05028]\]. However, Capo et al. showed in 2015 that neutrophils extracted from the blood of sportsmen whose diet had been supplemented with DHA and EPA secreted lower amounts of IL-6 upon PMA stimulation \[[@B79-ijms-20-05028]\]. A single report in 2018 investigated the effects of Resolvin D1 on NET production, i.e., in an abdominal aortic aneurysm mouse model Resolvin D1 decreased NET formation \[[@B80-ijms-20-05028]\]. We were not able to find a single report investigating the effect of omega-3 fatty acids on neutrophil degranulation.

Finally, although lipid rafts have been shown to be important for neutrophil's rolling \[[@B81-ijms-20-05028]\], to our knowledge, not a single report has demonstrated a direct link between omega-3 fatty acids incorporation into the cellular membrane of neutrophils and its impact on lipid raft formation and neutrophil function.

4. Effects of Omega-3 Fatty Acids on T Cells {#sec4-ijms-20-05028}
============================================

T cells are thymus-derived lymphocytes that recognize antigens presented by antigen presenting cells (APCs) through the T cell receptor (TCR). They comprise a heterogeneous group of cells with different immune properties, which makes their classification complex. T cells are classically classified into two main subsets, CD4+ T cells and CD8+ T cells, depending on their surface expression of CD4 or CD8 molecules, respectively. Both subsets differ on immune properties and functions. Whereas CD4+ T cells play major roles against bacterial infections, CD8 T cells mediate the immune response against viral infections. Additionally, T cells can be classified into helper (Th) and cytotoxic T cells. Th cells regulate the function of other immune cells whereas cytotoxic cells destroy virus-infected cells.

CD4+ helper T (Th) cells differentiate into different subgroups: Th1, Th2, Th17, and Th22 \[[@B82-ijms-20-05028]\]. Each subgroup produces and secretes different cytokines in response to stimulation. Th1 are characterized by their secretion of IFN-γ, Th2 secrete IL-4, Th17 secrete IL-17A, IL17-F, IL-21 \[[@B83-ijms-20-05028]\], and IL-22 and Th22 secrete IL-22.

Regulatory T cells (Tregs) suppress the activation of other immune cells such as Th1 CD4+ T cells, Th17 CD4+ T cells, CD8+ T cells, B cells, macrophages, or dendritic cells and maintain peripheral self-tolerance. The immunosuppressive effects of Tregs are exerted via the secretion of IL-10 and TGF-β \[[@B84-ijms-20-05028]\].

Pro-inflammatory T cells are the cytotoxic CD8+ T cells and the CD4+ Th1 and Th17 cells. Th1 and Th17 cells are derived from CD4+ T cells upon stimulation with antigenic peptides and specific combination of cytokines \[[@B85-ijms-20-05028]\]. Th17 cells are differentiated from naïve CD4+ T cells upon stimulation of IL-6 and TGF-β, which activate STAT3 and the transcription factor ROR-γt \[[@B86-ijms-20-05028]\].

4.1. General Effects of Omega-3 Fatty Acids on T Cells {#sec4dot1-ijms-20-05028}
------------------------------------------------------

T cells are first activated by the interaction of the T cell receptor (TCR) with APCs such as macrophages or dendritic cells. Therefore, alterations in the activation of APCs by omega-3 fatty acids are the first mechanisms by which omega-3 fatty acids may modulate T cell activation in vivo \[[@B87-ijms-20-05028],[@B88-ijms-20-05028]\]. However, direct effects of omega-3 fatty acids have also been described in the literature.

Evidence from multiple studies in vitro and in animal models concurs on a general suppressive effect of dietary omega-3 on T cell function \[[@B89-ijms-20-05028],[@B90-ijms-20-05028]\]. In fact, omega-3 fatty acid supplementation has been shown to have beneficial effects in several T-mediated diseases such as autoimmune hepatitis \[[@B91-ijms-20-05028]\] and asthma \[[@B92-ijms-20-05028]\]. However, the modulatory effect of omega-3 fatty acids differs for each phenotypic subgroup of T cells.

No changes in the percentage of T cells in blood have been found in mice fed with a diet rich in omega-3 fatty acids \[[@B93-ijms-20-05028]\], although an increase in Tregs and Th22 and a decrease in Th1, Th2, and Th17 cells was found in omega-3-fed mice after induction of colitis \[[@B93-ijms-20-05028]\]. No alterations on the percentage of T cells or T cell populations have been found in blood in humans after supplementation with omega-3 fatty acids \[[@B77-ijms-20-05028],[@B94-ijms-20-05028]\].

The effects of dietary omega-3 fatty acids on the abundance of T cells in the spleen is still not clear. Whereas Monk et al. reported an increase in the number of CD4+ and CD8+ T cells in the spleen of mice fed a diet rich in fish oil \[[@B95-ijms-20-05028]\], we have recently showed that a similar diet does not induce any changes in the percentages of both populations in the spleen \[[@B75-ijms-20-05028]\]. However, Monk et al. showed in a previous study that the omega-3-rich diet does not alter the abundance of Tregs, Th17 or Th1 cells in the spleen of mice \[[@B96-ijms-20-05028]\].

4.2. Specific Effects of Omega-3 Fatty Acids on the Different Subgroups of T Cells {#sec4dot2-ijms-20-05028}
----------------------------------------------------------------------------------

### 4.2.1. CD4 T Cells {#sec4dot2dot1-ijms-20-05028}

Metabolites derived from omega-3 fatty acids, i.e., SPMs, not only prevent differentiation of human CD4+ cells into Th1 cells, but also blunt the secretion of IFN-γ, IL-17, and IL-2 by human CD4+ T cells and TNF-α, IFN-γ, and IL-2 secretion by activated human CD8+ T cells \[[@B97-ijms-20-05028]\], although, without inducing any changes in T cell viability or proliferation. Similarly, ex vivo activation of CD4+ T cells isolated from the spleen of mice fed a diet rich in omega-3 fatty acids is reduced in comparison with cells isolated from mice fed a normal diet \[[@B95-ijms-20-05028]\]. This effect is mediated by an omega-3 fatty acid--induced decrease in the localization of signaling proteins and mitochondria at the immunological synapse \[[@B98-ijms-20-05028],[@B99-ijms-20-05028]\]. In contrast to the case for human cells, however, omega-3 fatty acids decrease the proliferation of mouse CD4+ T cells \[[@B12-ijms-20-05028],[@B100-ijms-20-05028]\].

Lipid rafts are important for the activation of CD4+ T cells \[[@B101-ijms-20-05028]\]. Incorporation of omega-3 fatty acids into the membrane of CD4+ T cells from mice induces changes in the membrane domains organization both in mice \[[@B102-ijms-20-05028]\] and human cells \[[@B103-ijms-20-05028]\], which could account for the above mentioned effects of omega-3 fatty acids on CD4 T cell function.

### 4.2.2. Th17 Cells {#sec4dot2dot2-ijms-20-05028}

Research on multiple animal models has proved that omega-3 fatty acids blunt Th17 differentiation and activation. Treatment of CD4+ T cells isolated from human blood with anti-CD3 and anti-TNF-α induces the differentiation of cells towards Th17 cells in vitro. This increase in Th17 differentiation is prevented by the addition of EPA to the cells \[[@B104-ijms-20-05028]\]. Similarly, CD4+ T cells differentiation into Th17 is blunted by omega-3 derived lipid mediators in human cells and in vivo in mouse models \[[@B97-ijms-20-05028]\]. In wild-type mice fed a diet rich in omega-3 fatty acids and in the *fat-1* mouse model, which produces higher levels of endogenous omega-3 fatty acids, CD4+ T cells failed to activate Stat-3 in response to pro-Th17 signals compared to control mice \[[@B95-ijms-20-05028],[@B105-ijms-20-05028]\].

In accordance to the decrease in the differentiation of CD4+ T cells into Th17 cells, omega-3 fatty acid supplementation reduces IL-17 plasma levels in children with asthma \[[@B92-ijms-20-05028]\]. Limitation of IL-17 plasma levels by dietary omega-3 fatty acids improves the severity of autoimmune uveitis in mice \[[@B106-ijms-20-05028]\].

### 4.2.3. Regulatory T Cells {#sec4dot2dot3-ijms-20-05028}

Due to their immune-regulatory properties, Tregs play important roles in many immune diseases. As such, the effects of omega-3 fatty acids on Tregs have been the focus of more extensive investigation than other subtypes of T cells. Dietary omega-3 fatty acids promote the accumulation and proliferation of Tregs in the liver \[[@B107-ijms-20-05028]\], spleen \[[@B108-ijms-20-05028]\] and in adipose tissue \[[@B87-ijms-20-05028]\] of wild-type mice. Also, *fat-1* mice present higher numbers of splenic Tregs due to enhanced differentiation towards Treg phenotype due to the increased production of endogenous omega-3 fatty acids \[[@B109-ijms-20-05028]\].

Both EPA and DHA promote the proliferation in vitro of CD4+ CD25+ cells isolated from mice into Tregs \[[@B19-ijms-20-05028],[@B107-ijms-20-05028]\]. In vivo, differentiation of T cells into Tregs has been found to be enhanced by the omega-3 fatty acid--mediated increase in M2 macrophages, as M2 macrophages directly induce Treg differentiation \[[@B87-ijms-20-05028],[@B110-ijms-20-05028]\].

The promotion of CD4+ T cell differentiation into Tregs by dietary omega-3 fatty acids has been successfully employed to reduce the severity of diseases such as arthritis and atopic dermatitis in mouse models \[[@B109-ijms-20-05028],[@B110-ijms-20-05028]\].

5. Effects of Omega-3 Fatty Acids on B Cells {#sec5-ijms-20-05028}
============================================

B cells are, together with T cells, the main lymphocytes of the adaptive branch of the immune response. Although the main classical function attributed to B cells is the production of antibodies, recent studies highlight B cell capacity of response to innate immune stimuli, such as PAMPs, and their important role in the regulation of the immune response via antigen presentation and cytokine production.

B cells originate in the bone marrow from hematopoietic stem cells (HSCs). HSCs differentiate into pro-B cells, the state at which heavy chain immunoglobulin rearrangement starts, and subsequently to pre-B cells, when the light chain immunoglobulin rearrangement starts. Once the immunoglobulin rearrangement is completed, the B cell receptor is fully functional, and B cells become immature B cells. After being tested for auto-reactivity, immature B cells migrate to the spleen, where they undergo further differentiation into follicular B cells or marginal zone B cells, via two transitional differentiation steps known as transitional type 1 B cells and transitional type 2 B cells \[[@B111-ijms-20-05028]\].

Additionally, one type of innate-like B cells, known as B1 cells, has been characterized, \[[@B112-ijms-20-05028]\]. B1 cells can function as antigen presenting cells and produce antibodies like conventional B cells (also known as B2 cells) but are more often present in peripheral tissues like the peritoneal cavity than in blood \[[@B113-ijms-20-05028]\].

5.1. Effects of Omega-3 Fatty Acids on B Cell Populations {#sec5dot1-ijms-20-05028}
---------------------------------------------------------

A diet rich in omega-3 fatty acids exerts alterations in the percentages of the different B cell populations in different tissues in mice. Mice fed a diet rich in omega-3 fatty acids from fish oil present a decreased amount of naïve B cells and mature B cells in the bone marrow but no changes in the percentages of pre-B cells or pro-B cells \[[@B114-ijms-20-05028]\]. However, a diet rich in omega-3 fatty acids from fish oil does not alter the percentage of B1 or B2 cells in the peritoneal cavity \[[@B115-ijms-20-05028],[@B116-ijms-20-05028]\]. In the spleen, the proportion between the different B cell populations is altered by dietary omega-3 fatty acids from fish oil while the total number of splenic B cells remains the same \[[@B75-ijms-20-05028],[@B117-ijms-20-05028],[@B118-ijms-20-05028]\]. Specifically, mice fed a diet enriched with fish oil omega-3 have increased numbers of transitional type 1 B cells in the spleen \[[@B114-ijms-20-05028],[@B115-ijms-20-05028]\], whereas mice fed diet enriched with DHA or with EPA present higher numbers of both transitional type 1 B and transitional type 2 B cell populations \[[@B117-ijms-20-05028]\]. Finally, dietary EPA supplementation increases the amount of total B cells in the adipose tissue of mice \[[@B87-ijms-20-05028]\].

5.2. Effects of Omega-3 Fatty Acids on B Cell Activation and Antibody Production {#sec5dot2-ijms-20-05028}
--------------------------------------------------------------------------------

B cells can be activated by both the interaction with other immune cells, such as T cells or neutrophils, or by directly binding pathogen-associated molecular patterns (PAMPs) \[[@B119-ijms-20-05028]\]. In response to stimulation, B cells increase the surface expression of several molecules, including CD80, CD86, MCH class II, and CD40 \[[@B120-ijms-20-05028]\].

DHA and EPA have a negative effect on the immune activation of B cells extracted from human PBMCs and treated ex vivo. EPA and DHA decrease anti-CD-40-induced p50 nuclear translocation, phosphorylation of Stat6 and secretion of IL-6 \[[@B121-ijms-20-05028]\]. The DHA-derived metabolite 17-hDHA decreases IL-6 and IL-10 secretion by human B cells upon stimulation with TLR agonist CpG ODN 2395 and anti-IgM \[[@B122-ijms-20-05028]\].

However, current results regarding the effect of omega-3 fatty acids on B cell activation on mouse present some contradictions. On one hand, B cells isolated from the spleen of mice previously fed with diets rich in omega-3 fatty acids secrete less IL-6 upon ex vivo stimulation with LPS \[[@B14-ijms-20-05028],[@B123-ijms-20-05028]\] and less IL-12 upon ex vivo stimulation with T cells \[[@B124-ijms-20-05028]\]. In these conditions, omega-3 fatty acids did not alter B cell activation marker expression, such as CD80, CD69, MHC II, or CD80. On the other hand, in vivo analysis of splenic B cell activation in mice revealed that a diet rich in omega-3 fatty acids increases levels of CD69, MHC II, and CD11c \[[@B14-ijms-20-05028],[@B123-ijms-20-05028]\]. Interestingly, whether the analysis of the activation of B cells was done after ex vivo incubation with omega-3 or in vivo in mice fed with omega-3-rich diets, omega-3 fatty acids does not alter the proportion of B cells that get activated \[[@B123-ijms-20-05028],[@B124-ijms-20-05028]\].

Studies regarding the effects of omega-3 fatty acids on the activation of B cell lymphoblasts confirm the blunting effect on B cell activation by omega-3 fatty acids, although the data is scarce. Shaikh et al. reported that JY B lymphoblasts are less susceptible to be lysed by alloreactive CD8 T cells after incubation with DHA due to decreased MHC I expression and decreased conjugate formation \[[@B125-ijms-20-05028]\]. Verlengia et al. showed that Raji cells stimulated with Concanavalin A secreted less IL-10, TNF-α, and IFN-γ after incubation with EPA or DHA \[[@B126-ijms-20-05028]\].

Although most studies to date conclude that omega-3 fatty acids reduce B cell activation to a certain extent, there is still some controversy in the field. A possible source of variability in these experiments is the fish oil added to the mice diet as a source of omega-3 fatty acids, as different fish oils have different effects on B cell activation even if they induce a similar accumulation of omega-3 fatty acids on the cellular membrane \[[@B127-ijms-20-05028]\].

Interestingly, despite most of the current evidence pointing to the dampening effect of omega-3 fatty acids on B cell activation, both EPA and DHA increase IgM production by B cells by increasing the number of antibody-producing cells in mouse and human \[[@B114-ijms-20-05028],[@B117-ijms-20-05028],[@B122-ijms-20-05028]\]. This effect is quite specific for IgM since omega-3 fatty acids do not alter B cell production of IgA, IgG, or IgD \[[@B114-ijms-20-05028],[@B121-ijms-20-05028]\].

6. Effects of Omega-3 Fatty Acids on Other Immune Cells {#sec6-ijms-20-05028}
=======================================================

Less extensive investigation has been performed on the effects of omega-3 fatty acids on other immune cells besides macrophages, neutrophils, T cells, and B cells. In the following section, we summarize the main findings regarding the alterations on other immune cells functions caused by omega-3 fatty acids.

6.1. Dendritic Cells {#sec6dot1-ijms-20-05028}
--------------------

Dendritic cells play an important role in the activation and regulation of the adaptive immune system thanks to their role as APCs \[[@B128-ijms-20-05028]\]. It is in this context that the effects of omega-3 fatty acids on dendritic cells has mainly been investigated. The omega-3 fatty acids DHA and EPA cause a down regulation of the MHC II and co-stimulatory molecules in the surface of mouse and human dendritic cells \[[@B129-ijms-20-05028],[@B130-ijms-20-05028],[@B131-ijms-20-05028],[@B132-ijms-20-05028]\]. As a direct consequence, the activation of T cells by omega-3 fatty acids--treated dendritic cells is severely impaired \[[@B88-ijms-20-05028],[@B131-ijms-20-05028],[@B133-ijms-20-05028],[@B134-ijms-20-05028],[@B135-ijms-20-05028]\].

6.2. Natural Killer Cells {#sec6dot2-ijms-20-05028}
-------------------------

Natural killer (NK) cells are innate lymphocytes that mediate the immune response against tumor and viruses. In contrast with cytotoxic CD8+ T cells, NK cells do not require prior contact with an antigen for their activation \[[@B136-ijms-20-05028]\]. To date, little is known regarding the effects of omega-3 fatty acids on NK function, and the current evidence is often contradictory. Whereas it was reported that dietary DHA promotes activation of splenic NK cells in mouse \[[@B137-ijms-20-05028]\], the opposite was found in a mouse model of influenza infection \[[@B138-ijms-20-05028]\]. In humans, dietary supplementation with EPA-rich oil did not alter the number of circulating NK cells \[[@B94-ijms-20-05028]\]. However, a similar study two years later found that dietary supplementation of DHA and EPA lowered the percentage of NK cells in blood \[[@B77-ijms-20-05028]\]. The effects of omega-3 fatty acid supplementation on NK cells in humans might be age-dependent, since EPA decreases NK cell activity in humans older than 55 years \[[@B139-ijms-20-05028]\].

6.3. Mast Cells {#sec6dot3-ijms-20-05028}
---------------

Mast cells are innate immune cells that have been classically associated with allergic processes. They bind IgE secreted by B cells through their high affinity IgE receptor (FcϵRI receptor). The interaction of an antigen with the IgE-FcϵRI receptor complex initiates a signaling cascade that culminates with mast cell degranulation \[[@B140-ijms-20-05028]\]. Omega-3 fatty acids decrease IgE-mediated activation of mast cells in several animal models and in human cells \[[@B141-ijms-20-05028],[@B142-ijms-20-05028],[@B143-ijms-20-05028]\]. The dampening effect of omega-3 fatty acids on mast cell activation has been employed to decrease the severity of mast cell-associated diseases such as allergy or atopic dermatitis \[[@B141-ijms-20-05028],[@B144-ijms-20-05028],[@B145-ijms-20-05028],[@B146-ijms-20-05028]\]. However, fish oil supplementation in asthmatic patients failed to ameliorate their symptoms \[[@B147-ijms-20-05028]\].

6.4. Basophils {#sec6dot4-ijms-20-05028}
--------------

Basophils are the least frequent granulocyte immune cell type present in blood. Their function and immunological properties are similar to those of mast cells, therefore they also play important roles in allergy and asthma \[[@B148-ijms-20-05028]\]. Treatment of basophilic leukemia cells with EPA and DHA reduces basophil activation in vitro \[[@B149-ijms-20-05028],[@B150-ijms-20-05028]\]. In healthy humans, dietary supplementation with omega-3 fatty acids decreases circulating levels of basophils \[[@B151-ijms-20-05028]\]. In asthmatic patients, dietary supplementation with botanical omega-3 fatty acids decreases basophil production of leukotrienes ex vivo \[[@B152-ijms-20-05028]\].

6.5. Eosinophils {#sec6dot5-ijms-20-05028}
----------------

Together with neutrophils and basophils, eosinophils are part of the granulocyte family of innate immune cells. Similarly to mast cells and basophils, they mediate immune reactions in allergic diseases \[[@B153-ijms-20-05028]\]. Oral administration of omega-3 fatty acids decreases the recruitment of eosinophils into the airways in eosinophilic airway inflammation murine models as well as eosinophil infiltration in a murine atopic dermatitis model, murine allergic conjunctivitis model and a rat skin allergy model \[[@B141-ijms-20-05028],[@B154-ijms-20-05028],[@B155-ijms-20-05028],[@B156-ijms-20-05028],[@B157-ijms-20-05028]\]. However, eosinophil numbers in the adipose tissue are increased upon EPA supplementation in lean and obese mice \[[@B87-ijms-20-05028]\]. In humans, supplementation with omega-3 fatty acid decreases the amount of circulating eosinophils in healthy volunteers \[[@B151-ijms-20-05028]\], but it failed to induce any changes in sputum eosinophilic count in asthmatic patients \[[@B147-ijms-20-05028]\]. The suppressive effect of omega-3 fatty acids on eosinophil tissue infiltration could be related to the inhibitory effect on eosinophil proliferation and migration by DHA found in vitro \[[@B158-ijms-20-05028],[@B159-ijms-20-05028]\].

7. Concluding Remarks {#sec7-ijms-20-05028}
=====================

In the present review, we have summarized the main findings regarding the immunomodulatory effects of omega-3 fatty acids on the different cells that conform the immune system (summarized in [Table 1](#ijms-20-05028-t001){ref-type="table"}). To our knowledge, from all the immune cells investigated to date, none of them has been found to be inert to dietary omega-3 fatty acids. Generally, ALA, DHA, and EPA exert an inhibitory effect on the activation of immune cells from both the innate and the adaptive branch. Interestingly, some specific immune functions are promoted by dietary omega-3 fatty acids in specific immune cell types, i.e., phagocytosis by macrophages and neutrophils or Treg differentiation, suggesting that omega-3 fatty acids do not act as unspecific immune-repressors.

Variations between different reports may lay on the different protocols for the incorporation of omega-3 fatty acids in in vitro cell culture, for example different concentrations or incubation times, or in vivo, e.g., different amounts of omega-3 fatty acids, proportions between omega-3 and omega-6 in the diet, duration of the supplementation, etc. Moreover, in order to correctly interpret the results from the investigations regarding the effects of dietary omega-3 fatty acids in vivo, the differences in fatty acid metabolism between different animal models should be taken into consideration. For example, dietary supplementation of omega-3 fatty acids increases omega-3 fatty acid blood levels more efficiently compared with employing the *fat-1* transgenic mouse model, particularly for EPA \[[@B160-ijms-20-05028]\]. Further, findings in mouse models may not be directly translated into humans since both organisms have differences at the immunological and metabolic levels. Often, dietary supplementation of omega-3 fatty acids in humans contains lower levels of EPA or DHA and is maintained for shorter time-periods compared with dietary supplementation of omega-3 fatty acids in mouse experiments. Additionally, while mouse diet is completely under the control of the investigator, human diet is more complex and heterogeneous, which could interfere with the effects of omega-3 fatty acid supplementation. To date, two main indices have been used to quantify the enrichment of the diet on omega-3 fatty acids: the n-3/n-6 ratio and the omega-3 index. Recent reports suggest a new index, named PUFA balance, which may improve the evaluation of omega-3 supplementation in humans and animal models \[[@B161-ijms-20-05028],[@B162-ijms-20-05028]\].

Although great progress has been made in our understanding of the effects of omega-3 fatty acids on the cells of the immune system, we still do not fully comprehend the precise mechanisms by which omega-3 fatty acids exert their immunoregulatory effects. How many of the effects exerted by omega-3 fatty acids rely on their localization on the cellular membrane? How many of them rely on the activation of transcription factors? Are the transcription factors activated by omega-3 fatty acids the same in all immune cells?

Omega-3 fatty acids ameliorate symptoms in several animal disease models, such as sepsis or autoimmune hepatitis, and have been tested in clinical trials with positive outcome. Getting detailed knowledge about the particular direct effects of omega-3 fatty acids on the different cells of the immune system will allow future investigators and clinicians to further optimize and implement omega-3 supplementation for the treatment of multiple diseases.
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ALA

Alpha (α)-linolenic acid

DHA

docosahexaenoic acid

EPA

eicosapentaenoic acid

PAMPS

pathogen-associated molecular patterns

PUFAs

polyunsaturated fatty acids

ROS

reactive oxygen species

SPMs

pro-resolving mediators

![Main biochemical pathways for the synthesis of omega-3 derived metabolites. The figure shows the omega-3 fatty acids α-linolenic acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA), their downstream metabolites and the enzymes regulating their synthesis.](ijms-20-05028-g001){#ijms-20-05028-f001}
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###### 

Summary of the properties of omega-3 fatty acids and their mediators on the different cells of the immune system including main references.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Cell Type                             Effect                                                                                                                                                   References
  ------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Macrophages                           ↓ cytokines                                                                                                                                              Cytokine production and secretion\
                                                                                                                                                                                                 \[[@B29-ijms-20-05028],[@B30-ijms-20-05028],[@B31-ijms-20-05028],[@B32-ijms-20-05028],[@B33-ijms-20-05028],[@B34-ijms-20-05028],[@B35-ijms-20-05028],[@B36-ijms-20-05028],[@B37-ijms-20-05028],[@B39-ijms-20-05028],[@B40-ijms-20-05028],[@B41-ijms-20-05028],[@B42-ijms-20-05028]\]\
                                                                                                                                                                                                 Signaling \[[@B28-ijms-20-05028],[@B38-ijms-20-05028],[@B44-ijms-20-05028],[@B45-ijms-20-05028],[@B46-ijms-20-05028],[@B47-ijms-20-05028]\]

  ↑ polarization towards M2 phenotype   \[[@B29-ijms-20-05028],[@B30-ijms-20-05028],[@B49-ijms-20-05028]\]\                                                                                      
                                        Stroke \[[@B50-ijms-20-05028]\]\                                                                                                                         
                                        Atopic dermatitis \[[@B51-ijms-20-05028]\]                                                                                                               

  ↑ phagocytosis                        Zymosan \[[@B29-ijms-20-05028]\]\                                                                                                                        
                                        *R.equi, P.aeruginosa* \[[@B52-ijms-20-05028]\]\                                                                                                         
                                        *E.coli* \[[@B53-ijms-20-05028]\]\                                                                                                                       
                                        Apoptotic cells \[[@B29-ijms-20-05028]\]                                                                                                                 

  Neutrophils                           ↑ production of pro-resolving mediators                                                                                                                  \[[@B61-ijms-20-05028],[@B62-ijms-20-05028]\]

  ↓ migration                           \[[@B63-ijms-20-05028],[@B64-ijms-20-05028],[@B65-ijms-20-05028],[@B66-ijms-20-05028],[@B67-ijms-20-05028],[@B68-ijms-20-05028],[@B71-ijms-20-05028]\]   

  ↑ phagocytosis                        Particles \[[@B72-ijms-20-05028]\]\                                                                                                                      
                                        *C. albicans* \[[@B4-ijms-20-05028]\]\                                                                                                                   
                                        *E.coli* \[[@B73-ijms-20-05028],[@B74-ijms-20-05028]\]\                                                                                                  
                                        Zymosan \[[@B70-ijms-20-05028]\]                                                                                                                         

  ↔ ROS production                      Rat \[[@B4-ijms-20-05028]\]\                                                                                                                             
                                        Goat \[[@B73-ijms-20-05028]\]\                                                                                                                           
                                        Human \[[@B70-ijms-20-05028],[@B74-ijms-20-05028]\]                                                                                                      

  ↑ frequency                           \[[@B72-ijms-20-05028],[@B75-ijms-20-05028],[@B76-ijms-20-05028]\]                                                                                       

  Eosinophils                           ↓ infiltration                                                                                                                                           Airway inflammation \[[@B155-ijms-20-05028]\]\
                                                                                                                                                                                                 Skin \[[@B141-ijms-20-05028],[@B156-ijms-20-05028]\]\
                                                                                                                                                                                                 Allergy \[[@B154-ijms-20-05028],[@B157-ijms-20-05028]\]

  Basophils                             ↓ activation                                                                                                                                             \[[@B149-ijms-20-05028],[@B150-ijms-20-05028],[@B152-ijms-20-05028]\]

  Dendritic cells                       ↓ antigen presentation                                                                                                                                   \[[@B88-ijms-20-05028],[@B129-ijms-20-05028],[@B130-ijms-20-05028],[@B131-ijms-20-05028],[@B133-ijms-20-05028],[@B134-ijms-20-05028]\]

  NK cells                              ↔ activation                                                                                                                                             \[[@B137-ijms-20-05028],[@B138-ijms-20-05028],[@B139-ijms-20-05028]\]

  Mast cells                            ↓ activation                                                                                                                                             \[[@B141-ijms-20-05028],[@B142-ijms-20-05028],[@B143-ijms-20-05028],[@B144-ijms-20-05028],[@B145-ijms-20-05028],[@B146-ijms-20-05028]\]

  T cells                               ↓ activation                                                                                                                                             General effects \[[@B87-ijms-20-05028],[@B88-ijms-20-05028],[@B89-ijms-20-05028],[@B90-ijms-20-05028],[@B91-ijms-20-05028],[@B92-ijms-20-05028]\]\
                                                                                                                                                                                                 CD4+ T cells \[[@B95-ijms-20-05028],[@B97-ijms-20-05028],[@B98-ijms-20-05028],[@B99-ijms-20-05028]\]\
                                                                                                                                                                                                 Th17 T cells \[[@B92-ijms-20-05028],[@B95-ijms-20-05028],[@B97-ijms-20-05028],[@B104-ijms-20-05028],[@B105-ijms-20-05028],[@B106-ijms-20-05028]\]

  ↑ Treg differentiation                \[[@B19-ijms-20-05028],[@B87-ijms-20-05028],[@B107-ijms-20-05028],[@B108-ijms-20-05028],[@B109-ijms-20-05028],[@B110-ijms-20-05028]\]                    

  B cells                               ↔ activation                                                                                                                                             Human \[[@B121-ijms-20-05028],[@B122-ijms-20-05028],[@B125-ijms-20-05028],[@B126-ijms-20-05028]\]\
                                                                                                                                                                                                 Mouse \[[@B14-ijms-20-05028],[@B123-ijms-20-05028],[@B124-ijms-20-05028]\]

  ↑ IgM production                      \[[@B114-ijms-20-05028],[@B117-ijms-20-05028],[@B121-ijms-20-05028],[@B122-ijms-20-05028]\]                                                              
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

↓ indicates a decrease, ↑ indicates an increase, ↔ indicates contradictive evidence.
